Frederica, Delaware, December 9, 2020 – ILC Dover, a world leader in the design and production of single-use flexible solutions for pharmaceutical and biopharmaceutical manufacturing, today named David Radspinner as President of the Pharmaceutical/Biopharmaceutical Business Unit, effective December 14, 2020.
In his new role, Dr. Radspinner is expected to contribute to ILC Dover’s continued growth by building and leading a high-performance team to deliver high-value single-use workflow solutions to global pharmaceutical and biopharmaceutical markets.
Dr. Radspinner brings extensive experience in global life sciences to ILC Dover. He previously served as Vice President & General Manager, Global Commercial Transition at Cytiva (previously GE Healthcare) and other senior roles. Prior to Cytiva, David held roles of increasing scope and responsibility at Thermo-Fisher Scientific, Sanofi-Aventis, and Eli Lilly & Co.
“ILC Dover is extremely pleased to welcome Dr. David Radspinner to the team,” said Fran DiNuzzo, President & CEO of ILC Dover. “David’s extensive background driving profitable growth for world-leading organizations will support our own strategic goals in expanding our single-use flexible solutions for critical markets. We look forward to leveraging his strong leadership and life sciences experience for years to come.”
David Radspinner earned his PhD in Analytical Chemistry from University of Arizona and holds a bachelor’s degree in chemistry from Wabash College.
About ILC Dover
ILC Dover is a world-leader in the innovative design and production of engineered flexible protective solutions for pharmaceutical and biopharmaceutical, flood protection, personal protection, bulk packaging, and aerospace industries. Our customers will attest to our relentless dedication to high value products, advanced technology, and responsive service, as our visionary solutions have improved efficiency while safeguarding people, product, and infrastructure in hazardous conditions through flexible protective solutions since 1947. ILC Dover is a portfolio company of New Mountain Capital, a New York-based investment firm that accelerates growth. For more information, visit ILCDover.com or LinkedIn.
